All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes
2 Department of Biomedical Sciences, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, New York, USA
Histopathological examination detected no liver failure, and the cause of mortality was determined to be severe diarrhea
Of note, while confirming that NAFLD, diagnosed either by ultrasonography or liver enzymes, predicted incident T2D, another meta-analysis by Lallukka and Jarvinen [35] found that NAFLD associated with specific genetic traits was not associated with excess risk of incident T2D
New York, NY: McGraw-Hill